StonvexLoading…
StonvexStonvexStonvexCore line items from DAVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $174.01M | $158.41M | $554.18M | $390.46M | $239.74M |
Operating Income | Not available | $70.16M | $168.03M | $103.81M | $45.38M |
Net Income | Not available | $57.94M | $195.87M | $129.92M | $37.85M |
EPS (Diluted) | $3.43 | $4.02 | $13.53 | $8.96 | $2.61 |
Total Assets | Not available | $530.53M | $487.42M | $433.25M | $363.56M |
Total Liabilities | Not available | $326.75M | $134.69M | $141.94M | $146.49M |
Cash & Equivalents | Not available | $133.33M | $80.52M | $49.89M | $61.69M |
Free Cash Flow OCF − CapEx | Not available | $82.01M | $289.71M | $196.50M | $113.32M |
Shares Outstanding | Not available | 14.40M | 14.48M | 14.49M | 14.48M |